HighCape Partners GP II, LLC - 22 Dec 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 Dec 2022, 14:55:35 UTC
Prior SEC filing
15 Dec 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
HighCape Partners GP II, LLC By: /s/ W. Matthew Zuga Name: W. Matthew Zuga Title: Managing Member

Key filing fact

HighCape Partners GP II, LLC filed Form 4 for AZIYO BIOLOGICS, INC. (ELUT) on 28 Dec 2022.

Key facts

  • This page summarizes HighCape Partners GP II, LLC's Form 4 filing for AZIYO BIOLOGICS, INC. (ELUT).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 28 Dec 2022, 14:55.

Change

  • Previous filing in this sequence was filed on 15 Dec 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AZYO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+17,533
Change %
Price
$0.000000
Shares after
17,533
Date
22 Dec 2022
Ownership
See footnote
Underlying class
Class A Common Stock
Underlying amount
17,533
Exercise price
$3.80
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This option vests in full and shall be fully exercisable on June 20, 2023, subject to Mr. Rakin's continuing in service on the Issuer's board of directors through the vesting date.

Footnote F2

Granted to Kevin L. Rakin as non-employee member of the Issuer's board of directors.

SEC remarks

Due to the limitations of the electronic filing system, each of HighCape Capital, L.P., HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, W. Matthew Zuga and Kevin L. Rakin filed on a separate Form 4 dated December 27, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .